Modeling CLN3 Batten disease in astrocytes reveals alterations in mitochondria homeostasis, fatty acid metabolism and oxidative stress response [PDF]
Background CLN3 Batten disease is a severe pediatric neurodegenerative disorder caused by mutations in the CLN3 gene, most commonly a 1 kb deletion encompassing exons 7 and 8.
Mingyi Yang +12 more
doaj +2 more sources
Enteric nervous system degeneration in human and murine CLN3 disease, is ameliorated by gene therapy in mice [PDF]
Severe gastrointestinal (GI) symptoms occur in people with CLN3 disease, a neurodegenerative disorder. If left untreated these GI symptoms compromise life quality and may contribute to death.
Ewa A. Ziółkowska +11 more
doaj +2 more sources
Mutations in the lysosomal membrane protein CLN3 cause Juvenile Neuronal Ceroid Lipofuscinosis (JNCL). Activation of the lysosomal ion channel TRPML1 has previously been shown to be beneficial in several neurodegenerative disease models.
D. Wünkhaus +13 more
doaj +3 more sources
Functional ultrasound imaging reveals early pathway-specific reorganization of central visual circuits in a mouse model of Batten disease [PDF]
CLN3 disease, or juvenile Batten disease, is a neurodegenerative lysosomal storage disorder in which visual impairment is typically the earliest clinical manifestation.
Fanchao Yin +8 more
doaj +2 more sources
CLN3 mediates chloride efflux from lysosomes. [PDF]
Neurodegenerative diseases, which pose significant challenges for effective treatment, often involve risk variants of lysosomal gene products that disrupt lysosomal function, leading to the accumulation of indigestible materials and damage to brain cells. The lysosome is a degradative organelle and a signaling hub that senses nutrient availability. How
Wang Y +8 more
europepmc +5 more sources
Timing of cognitive decline in CLN3 disease [PDF]
AbstractBackgroundCLN3 disease is a major cause of childhood neurodegeneration. Onset of visual failure around 6 years of age is thought to precede cognitive deterioration by a few years, but casuistic reports question this paradigm. The aim of our study is to delineate timing of cognitive decline in CLN3 disease.MethodsEarly neurocognitive functioning
Kuper, Willemijn F.E. +5 more
openaire +4 more sources
Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease [PDF]
CLN3 disease is a fatal childhood neurodegenerative disorder without drug-modifying therapies. Wild-type CLN3 gene is anti-apoptotic. Previous work proves that CLN3 disease pathogenesis is associated with reduced cell viability/apoptotic cell death and ...
Fatima Bilal +7 more
doaj +2 more sources
Sex-specific and age-related progression of auditory neurophysiological deficits in the Cln3 mouse model of Batten disease [PDF]
Background CLN3 disease, also known as juvenile Batten disease, is a recessively inherited neurodevelopmental disorder caused by mutations in the CLN3 gene. It represents the most common form of Neuronal Ceroid Lipofuscinoses (NCLs), a group of lysosomal
Yanya Ding +8 more
doaj +2 more sources
Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnover [PDF]
Loss-of-function mutations in CLN3 cause juvenile Batten disease, featuring neurodegeneration and early-stage neuroinflammation. How loss of CLN3 function leads to early neuroinflammation is not yet understood.
Seda Yasa +12 more
doaj +2 more sources
TOR-dependent regulation of the yeast homolog of the juvenile Batten Disease-associated gene CLN3 [PDF]
The Juvenile form of Batten disease is a neurodegenerative disease with symptoms starting in the first decade and ending in death in the third decade of life. The gene defective in this form of Batten disease, CLN3, is conserved in eukaryotes, suggesting
Vijaykumar Pillalamarri +5 more
doaj +2 more sources

